| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Evogene (NASDAQ:EVGN) is gearing up to announce its quarterly earnings on Thursday, 2025-11-20. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Evogene will report an earnings per share (EPS) of $-0.41.
The announcement from Evogene is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
During the last quarter, the company reported an EPS beat by $0.13, leading to a 3.94% drop in the share price on the subsequent day.
Here's a look at Evogene's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.63 | -0.50 | -0.73 | -1.01 |
| EPS Actual | -0.50 | -0.38 | 0.06 | -1.31 |
| Price Change % | -4.00 | 0.00 | 5.00 | 1.00 |
Shares of Evogene were trading at $1.17 as of November 18. Over the last 52-week period, shares are down 26.88%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
To track all earnings releases for Evogene visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: EVGN
